• Clinical Insights

World Bipolar Day: Medication adherence more critical than ever

Mar 30th, 2020

Bipolar Disorder & The Pandemic

Marking World Bipolar Day to raise awareness and acceptance of bipolar disorder takes on special significance this year during the COVID-19 pandemic. Uncertainty about the disease and the social distancing required to slow its spread can deepen feelings of stress and isolation, particularly for those with mental illness. Research shows that for those living with bipolar disorder, sustained stress can have a serious negative impact.[1]

Self-care and maintaining familiar routines can ease stress and anxiety, according to the National Alliance on Mental Illness. Sticking with one’s medication regimen is also critically important, as straying from treatment can result in hospitalizations, emergency room visits and other negative outcomes. To be considered adherent, individuals must take at least 80% of their medications as prescribed. The average person living with bipolar disorder is only 41% adherent.[2]

Pharmacy Times recently published an article about the crucial role pharmacists can play in improving adherence for those living with bipolar disorder. Genoa Healthcare pharmacist Zenia Tal, PharmD, RPh said in the article, “Bipolar disorder is a lifelong condition, and I see my role in providing medication therapy management as helping empower patients to be as healthy as possible.”

Read the full article here to learn how pharmacists and medication management can play a key role in consumer care.


[1] https://www.psychologytoday.com/us/blog/bipolar-you/202003/surviving-bipolar-disorder-during-the-covid-19-pandemic

[2] Garcia S, Martinez-Cengotitabengoa M, Lopez-Zurbano S, et al. Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients. J Clin Psychopharmacol. 2016;36(4):355-371. doi: 10.1097/JCP.0000000000000523.

Recent Posts


Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Brixadi®: 3 things to know about the buprenorphine treatment option

Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...

  • People-first Pharmacy Care
Pharmacist Torquelia took a chance on herself to make a difference for others

If Torquelia Wynn, PharmD, sets her mind to something, it’s going to get done. The Thomasville, Georgia, Genoa Healthcare site manager grew up in Ashburn, Georgia – a small town...

  • Behavioral Health
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Healthcare® Director of Operations featured in Chain Drug Review’s “Excellence in Pharmacy Practice” profile series

Alicia Garcia Afa, PharmD, RPh, a Genoa Healthcare director of pharmacy operations and previous pharmacist who recently helped a consumer navigate a mental health crisis, was featured in Chain Drug Review’s pharmacy...

  • People-first Pharmacy Care
Whether in his community or across the world, pharmacist Dylan strives to make an impact

It doesn’t feel like enough to say Dylan Bryant, PharmD, wears many hats. He’s a Genoa Healthcare pharmacist in Hays, Kansas, a husband and a dad to three kids ages...